Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Phase of Trial: Phase I
Latest Information Update: 20 Nov 2012
At a glance
- Drugs Tipranavir (Primary) ; Buprenorphine/naloxone; Ritonavir
- Indications HIV infections; Opioid abuse
- Focus Pharmacokinetics
- Acronyms BUTI
- 16 Dec 2007 Status changed from recruiting to completed.
- 06 Jul 2007 New trial record.